Spontaneous bacterial peritonitis pathophysiology: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
SBP is a result of culmination of the inability of the gut to contain bacteria and failure of the [[immune system]] to eradicate the organisms once they have escaped.<ref name="pmid4018735">{{cite journal| author=Runyon BA, Morrissey RL, Hoefs JC, Wyle FA| title=Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. | journal=Hepatology | year= 1985 | volume= 5 | issue= 4 | pages= 634-7 | pmid=4018735 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4018735 }} </ref><ref name="pmid15138202">{{cite journal| author=Runyon BA| title=Early events in spontaneous bacterial peritonitis. | journal=Gut | year= 2004 | volume= 53 | issue= 6 | pages= 782-4 | pmid=15138202 | doi= | pmc=1774068 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15138202 }} </ref><ref name="pmid15920324">{{cite journal| author=Sheer TA, Runyon BA| title=Spontaneous bacterial peritonitis. | journal=Dig Dis | year= 2005 | volume= 23 | issue= 1 | pages= 39-46 | pmid=15920324 | doi=10.1159/000084724 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15920324 }} </ref> | SBP is a result of culmination of the inability of the gut to contain bacteria and failure of the [[immune system]] to eradicate the organisms once they have escaped.<ref name="pmid4018735">{{cite journal| author=Runyon BA, Morrissey RL, Hoefs JC, Wyle FA| title=Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. | journal=Hepatology | year= 1985 | volume= 5 | issue= 4 | pages= 634-7 | pmid=4018735 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4018735 }} </ref><ref name="pmid15138202">{{cite journal| author=Runyon BA| title=Early events in spontaneous bacterial peritonitis. | journal=Gut | year= 2004 | volume= 53 | issue= 6 | pages= 782-4 | pmid=15138202 | doi= | pmc=1774068 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15138202 }} </ref><ref name="pmid15920324">{{cite journal| author=Sheer TA, Runyon BA| title=Spontaneous bacterial peritonitis. | journal=Dig Dis | year= 2005 | volume= 23 | issue= 1 | pages= 39-46 | pmid=15920324 | doi=10.1159/000084724 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15920324 }} </ref>.'''[[Spontaneous bacterial peritonitis]] is thought to result from a combination of factors related to [[cirrhosis]] and [[ascites]] such as''': Altered microbial flora, Hypo-motility of the intestine, Intestinal bacterial overgrowth, Increased Intestinal mucosal [[permeability]], Bacterial translocation to [[Lymph nodes]]. Presence of [[ascites]] appears to be an important risk factor for the development of bacterial [[translocation]]. In healthy individuals, bacteria that colonize [[lymph nodes]] are killed by local immune defenses. '''However, in the setting of [[cirrhosis]], an [[acquired]] state of [[Immunodeficiency]] there is''': Malfunctioning of the [[Reticulo-endothelial system|reticulo-endothelial]] and neutrophilic system, Reduced [[Cellular]] and [[Humoral]] [[bactericidal]] function which favor the spread of [[bacteria]] to the [[blood stream]]. '''Alterations in the [[systemic]] [[immune response]]''': [[Bacteremia]] in a healthy host results in rapid coating by [[IgG]] and/or [[Complement]] components and then engulfing and killing by circulating [[neutrophils]]. '''But in [[cirrhosis]], as stated above several abnormalities have been described including''' : Decreased serum levels of [[complement]] components (C3, C4), Impaired [[chemotaxis]], Poor function and [[phagocytic]] activity of [[neutrophils]], Decreased function of [[Fc receptor|Fc]]-gamma-receptors in [[macrophages]]. '''[[Reticuloendothelial system]] [[phagocytic]] activity''': The stationary [[macrophages]], such as the [[Kupffer cell|Kupffer cells]] of the liver, assist the circulating [[neutrophils]] in the extraction and killing of particulate matter (e.g., bacteria) from the systemic circulation. In Cirrhosis, there is Hepatic [[Reticuloendothelial system]] (RES) dysfunction, [[Kupffer cells]] are decreased in number with impaired function along with the malfunctioning of the neutrophilic system. Patients with the most severe dysfunction of RES have the highest risk of [[bacteremia]] and concomitant shortened survival, due to [[sepsis]]. The presence of intrahepatic and extra hepatic porto-systemic shunts as a consequence of [[portal hypertension]], prevent circulating bacteria from encountering [[Kupffer cells]]. The final consequence of these abnormalities is the prolongation of [[bacteremia]] and eventual seeding of other sites, including AF. '''AF defense mechanisms:''' Decreased local AF opsonic activity: The arrival of bacteria to the AF does not guarantee that infection will develop. Cirrhotic AF is capable of [[humoral]] self-defense, mainly on the basis of effectiveness of the [[complement]] system, Patients with adequate activity of this vital [[bactericidal]] system usually do not develop AF bacterial infections, Patients with AF C3 < 1g/dl and a protein level < 1g/dl have an increased predisposition to [[SBP]], the [[complement]] levels may be deficient because of increased consumption of these components or because of impaired synthesis, if the [[complement]] levels are adequate to effectively kill the bacteria, infection will not develop, if [[complement]] levels are consumed and depleted, killing may be ineffective, frequent colonization of AF by bacteria decreases its antimicrobial ability and can eventually lead to the development of infection [[Bacteremia]]/ Endotoxemia leads to activation of [[cytokine]] cascade and some of these effector molecules and [[cytokines]] that help kill the bacteria have undesired side effects. [[NO]] and [[TNF]] are important mediators of the further [[vasodilation]] and [[renal failure]] that too often accompany [[SBP]]. [[Iatrogenic]] and treatment related factors like [[PPI]], and increased use of invasive procedures and catheters in patients with [[Cirrhosis]] and [[ascites]]. Other compelling factors like [[malnutrition]] and [[alcohol]] drinking also predispose to SBP. | ||
==Pathophysiology== | ==Pathophysiology== |
Revision as of 14:53, 3 February 2017
Spontaneous bacterial peritonitis Microchapters |
Differentiating Spontaneous bacterial peritonitis from other Diseases |
Diagnosis |
Treatment |
Spontaneous bacterial peritonitis pathophysiology On the Web |
American Roentgen Ray Society Images of Spontaneous bacterial peritonitis pathophysiology |
Spontaneous bacterial peritonitis pathophysiology in the news |
Directions to Hospitals Treating Spontaneous bacterial peritonitis |
Risk calculators and risk factors for Spontaneous bacterial peritonitis pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2] Shivani Chaparala M.B.B.S [3]
Overview
SBP is a result of culmination of the inability of the gut to contain bacteria and failure of the immune system to eradicate the organisms once they have escaped.[1][2][3].Spontaneous bacterial peritonitis is thought to result from a combination of factors related to cirrhosis and ascites such as: Altered microbial flora, Hypo-motility of the intestine, Intestinal bacterial overgrowth, Increased Intestinal mucosal permeability, Bacterial translocation to Lymph nodes. Presence of ascites appears to be an important risk factor for the development of bacterial translocation. In healthy individuals, bacteria that colonize lymph nodes are killed by local immune defenses. However, in the setting of cirrhosis, an acquired state of Immunodeficiency there is: Malfunctioning of the reticulo-endothelial and neutrophilic system, Reduced Cellular and Humoral bactericidal function which favor the spread of bacteria to the blood stream. Alterations in the systemic immune response: Bacteremia in a healthy host results in rapid coating by IgG and/or Complement components and then engulfing and killing by circulating neutrophils. But in cirrhosis, as stated above several abnormalities have been described including : Decreased serum levels of complement components (C3, C4), Impaired chemotaxis, Poor function and phagocytic activity of neutrophils, Decreased function of Fc-gamma-receptors in macrophages. Reticuloendothelial system phagocytic activity: The stationary macrophages, such as the Kupffer cells of the liver, assist the circulating neutrophils in the extraction and killing of particulate matter (e.g., bacteria) from the systemic circulation. In Cirrhosis, there is Hepatic Reticuloendothelial system (RES) dysfunction, Kupffer cells are decreased in number with impaired function along with the malfunctioning of the neutrophilic system. Patients with the most severe dysfunction of RES have the highest risk of bacteremia and concomitant shortened survival, due to sepsis. The presence of intrahepatic and extra hepatic porto-systemic shunts as a consequence of portal hypertension, prevent circulating bacteria from encountering Kupffer cells. The final consequence of these abnormalities is the prolongation of bacteremia and eventual seeding of other sites, including AF. AF defense mechanisms: Decreased local AF opsonic activity: The arrival of bacteria to the AF does not guarantee that infection will develop. Cirrhotic AF is capable of humoral self-defense, mainly on the basis of effectiveness of the complement system, Patients with adequate activity of this vital bactericidal system usually do not develop AF bacterial infections, Patients with AF C3 < 1g/dl and a protein level < 1g/dl have an increased predisposition to SBP, the complement levels may be deficient because of increased consumption of these components or because of impaired synthesis, if the complement levels are adequate to effectively kill the bacteria, infection will not develop, if complement levels are consumed and depleted, killing may be ineffective, frequent colonization of AF by bacteria decreases its antimicrobial ability and can eventually lead to the development of infection Bacteremia/ Endotoxemia leads to activation of cytokine cascade and some of these effector molecules and cytokines that help kill the bacteria have undesired side effects. NO and TNF are important mediators of the further vasodilation and renal failure that too often accompany SBP. Iatrogenic and treatment related factors like PPI, and increased use of invasive procedures and catheters in patients with Cirrhosis and ascites. Other compelling factors like malnutrition and alcohol drinking also predispose to SBP.
Pathophysiology
|
Diagramatic representation of pathological bacterial translocation and the associated host response
[17] Contrary to earlier theories, transmucosal migration of bacteria from the gut to the ascitic fluid is no longer considered to play a major role in the etiology of SBP.[16][3]
With respect to compromised host defenses, patients with severe acute or chronic liver disease are often deficient in complement and may also have malfunctioning of the neutrophilic and reticuloendothelial systems.[18]
As for the significance of ascitic fluid proteins, it was demonstrated that cirrhotic patients with ascitic protein concentrations below 1 g/dL were 10 times more likely to develop SBP than individuals with higher concentrations.[19] It is thought that the antibacterial, or opsonic, activity of ascitic fluid is closely correlated with the protein concentration.[1] Additional studies have confirmed the validity of the ascitic fluid protein concentration as the best predictor of the first episode of SBP.[18]
References
- ↑ 1.0 1.1 1.2 1.3 Runyon BA, Morrissey RL, Hoefs JC, Wyle FA (1985). "Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis". Hepatology. 5 (4): 634–7. PMID 4018735.
- ↑ 2.0 2.1 2.2 Runyon BA (2004). "Early events in spontaneous bacterial peritonitis". Gut. 53 (6): 782–4. PMC 1774068. PMID 15138202.
- ↑ 3.0 3.1 Sheer TA, Runyon BA (2005). "Spontaneous bacterial peritonitis". Dig Dis. 23 (1): 39–46. doi:10.1159/000084724. PMID 15920324.
- ↑ Llach J, Rimola A, Navasa M, Ginès P, Salmerón JM, Ginès A; et al. (1992). "Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration". Hepatology. 16 (3): 724–7. PMID 1505916.
- ↑ 5.0 5.1 Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taurá P; et al. (2001). "Bacterial translocation of enteric organisms in patients with cirrhosis". J Hepatol. 34 (1): 32–7. PMID 11211904.
- ↑ 6.0 6.1 Chang CS, Chen GH, Lien HC, Yeh HZ (1998). "Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis". Hepatology. 28 (5): 1187–90. doi:10.1002/hep.510280504. PMID 9794900.
- ↑ {{cite journal| author=Bauer TM, Steinbrückner B, Brinkmann FE, Ditzen AK, Schwacha H, Aponte JJ et al.| title=Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. | journal=Am J Gastroenterol | year= 2001 | volume= 96 | issue= 10 | pages= 2962-7 | pmid=11693333 | doi=10.1111/j.1572-0241.2001.04668.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11693333
- ↑ Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J (1984). "Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis". Hepatology. 4 (1): 53–8. PMID 6693068.
- ↑ Wiest R, Garcia-Tsao G (2005). "Bacterial translocation (BT) in cirrhosis". Hepatology. 41 (3): 422–33. doi:10.1002/hep.20632. PMID 15723320.
- ↑ Runyon BA, Squier S, Borzio M (1994). "Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis". J Hepatol. 21 (5): 792–6. PMID 7890896.
- ↑ 11.0 11.1 Ho H, Zuckerman MJ, Ho TK, Guerra LG, Verghese A, Casner PR (1996). "Prevalence of associated infections in community-acquired spontaneous bacterial peritonitis". Am J Gastroenterol. 91 (4): 735–42. PMID 8677940.
- ↑ 12.0 12.1 12.2 Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J; et al. (2001). "Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection". Dig Dis Sci. 46 (11): 2360–6. PMID 11713936.
- ↑ 13.0 13.1 Dunn DL, Barke RA, Knight NB, Humphrey EW, Simmons RL (1985). "Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity". Infect Immun. 49 (2): 257–64. PMC 262007. PMID 3894229.
- ↑ Titó L, Rimola A, Ginès P, Llach J, Arroyo V, Rodés J (1988). "Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors". Hepatology. 8 (1): 27–31. PMID 3257456.
- ↑ 16.0 16.1 Runyon BA (1988). "Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis". Hepatology. 8 (3): 632–5. PMID 3371881.
- ↑ 17.0 17.1 Runyon BA, Hoefs JC (1984). "Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis". Hepatology. 4 (6): 1209–11. doi:10.1002/hep.1840040619. PMID 6500513.
- ↑ 18.0 18.1 Alaniz C, Regal RE (2009) Spontaneous bacterial peritonitis: a review of treatment options. P T 34 (4):204-10. PMID: 19561863
- ↑ Runyon BA (1986) Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 91 (6):1343-6. PMID: 3770358